Stock Market Update
10-Mar-25 14:25 ET
S&P 500 drops as Palantir, Delta sink; Regeneron gains on positive Dupixent trial
Dow -870.08
at 41931.33,
Nasdaq -758.77
at 17437.46,
S&P -159.90
at 5610.30
[BRIEFING.COM] The S&P 500 (-2.77%) is in second place on Monday afternoon.
Briefly, S&P 500 constituents Palantir Technologies (PLTR 75.24, -9.67, -11.39%), Delta Air Lines (DAL 48.95, -4.33, -8.13%), and KKR (KKR 107.01, -8.26, -7.17%) dot the bottom of the average. PLTR is caught up in the outsized losses among tech stocks today, while DAL caught a tgt cut out of Bernstein to $66 from $75.
Meanwhile, Regeneron Pharma (REGN 738.57, +31.06, +4.39%) is near the top of the standings after the company and Sanofi (SNY) announced positive results from the pivotal ADEPT Phase 2/3 trial evaluating the investigational use of Dupixent in adults with moderate-to-severe bullous pemphigoid.
